题名

Antiviral Natural Products and Herbal Medicines

DOI

10.4103/2225-4110.124335

作者

Liang-Tzung Lin；Wen-Chan Hsu；Chun-Ching Lin

关键词

Antiviral ； Drug development ； Herbal medicines ； Natural products

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

4卷1期（2014 / 01 / 01）

页次

24 - 35

内容语文

英文
中文摘要

Viral infections play an important role in human diseases, and recent outbreaks in the advent of globalization and ease of travel have underscored their prevention as a critical issue in safeguarding public health. Despite the progress made in immunization and drug development, many viruses lack preventive vaccines and efficient antiviral therapies, which are often beset by the generation of viral escape mutants. Thus, identifying novel antiviral drugs is of critical importance and natural products are an excellent source for such discoveries. In this mini-review, we summarize the antiviral effects reported for several natural products and herbal medicines.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. World Health Organization: Available from: http://www.who.int. [Last accessed on 2013 Sep 18].
  2. Anggakusuma,Colpitts, CC,Schang, LM,Rachmawati, H,Frentzen, A,Pfaender, S(2013).Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.Gut
  3. Arduino, PG,Porter, SR(2008).Herpes Simplex Virus Type 1 infection: Overview on relevant clinico‑pathological features.J Oral Pathol Med,37,107-121.
  4. Back, AT,Lundkvist, A(2013).Dengue viruses‑an overview.Infect Ecol Epidemiol,3,19839.
  5. Ball, MJ,Lukiw, WJ,Kammerman, EM,Hill, JM(2013).Intracerebral propagation of Alzheimer’s disease: Strengthening evidence of a herpes simplex virus etiology.Alzheimers Dement,9,169-175.
  6. Barnard, DL(2004).Inhibitors of measles virus.Antivir Chem Chemother,15,111-119.
  7. Bertol, JW,Rigotto, C,de Padua, RM,Kreis, W,Barardi, CR,Braga, FC(2011).Antiherpes activity of glucoevatromonoside, a cardenolide isolated from a Brazilian cultivar of Digitalis lanata.Antiviral Res,92,73-80.
  8. Black, WCt,Bennett, KE,Gorrochotegui‑Escalante, N,Barillas‑Mury, CV,Fernandez‑Salas, I,de Lourdes Munoz, M(2002).Flavivirus susceptibility in Aedes aegypti.Arch Med Res,33,379-388.
  9. Braciale, TJ(2005).Respiratory syncytial virus and T cells: Interplay between the virus and the host adaptive immune system.Proc Am Thorac Soc,2,141-146.
  10. Burton, DR,Desrosiers, RC,Doms, RW,Koff, WC,Kwong, PD,Moore, JP(2004).HIV vaccine design and the neutralizing antibody problem.Nat Immunol,5,233-236.
  11. Calland, N,Albecka, A,Belouzard, S,Wychowski, C,Duverlie, G,Descamps, V(2012).(‑)‑Epigallocatechin‑3‑gallate is a new inhibitor of hepatitis C virus entry.Hepatology,55,720-729.
  12. Cascio, A,Bosilkovski, M,Rodriguez‑Morales, AJ,Pappas, G(2011).The socio‑ecology of zoonotic infections.Clin Microbiol Infect,17,336-342.
  13. Cesar, GZ,Alfonso, MG,Marius, MM,Elizabeth, EM,Angel, CB,Maira, HR(2011).Inhibition of HIV‑1 reverse transcriptase, toxicological and chemical profile of Calophyllum brasiliense extracts from Chiapas, Mexico.Fitoterapia,82,1027-1034.
  14. Chang, JS,Liu, HW,Wang, KC,Chen, MC,Chiang, LC,Hua, YC(2005).Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV‑producing cell line.Antiviral Res,66,29-34.
  15. Chang, JS,Wang, KC,Liu, HW,Chen, MC,Chiang, LC,Lin, CC(2007).Sho‑saiko‑to (Xiao‑Chai‑Hu‑Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV‑producing cell line.Am J Chin Med,35,341-351.
  16. Chang, LY,Tsao, KC,Hsia, SH,Shih, SR,Huang, CG,Chan, WK(2004).Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan.JAMA,291,222-227.
  17. Chen, SD,Gao, H,Zhu, QC,Wang, YQ,Li, T,Mu, ZQ(2012).HouttuynoidsA‑E, anti‑herpes simplex virus active flavonoids with novel skeletons from Houttuynia cordata.Org Lett,14,1772-1775.
  18. Cheng, HY,Huang, HH,Yang, CM,Lin, LT,Lin, CC(2008).The in vitro anti‑herpes simplex virus type‑1 and type‑2 activity of Long Dan Xie Gan Tan, a prescription of traditional Chinese medicine.Chemotherapy,54,77-83.
  19. Cheng, HY,Lin, LT,Huang, HH,Yang, CM,Lin, CC(2008).Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type‑1 and type‑2 infections in vitro.Antivir Res,77,14-19.
  20. Cheng, HY,Yang, CM,Lin, TC,Lin, LT,Chiang, LC,Lin, CC(2011).Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles.Evid Based Complement Alternat Med,2011,259103.
  21. Cheng, HY,Yang, CM,Lin, TC,Shieh, DE,Lin, CC(2006).ent‑Epiafzelechin‑(4alpha‑‑>8)‑epiafzelechin extracted from Cassia javanica inhibits herpes simplex virus type 2 replication.J Med Microbiol,55,201-206.
  22. Cheng, PW,Chiang, LC,Yen, MH,Lin, CC(2007).Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS‑1 cells by induction of type I interferons expression.Food Chem Toxicol,45,24-31.
  23. Cheng, PW,Ng, LT,Chiang, LC,Lin, CC(2006).Antiviral effects of saikosaponins on human coronavirus 229E in vitro.Clin Exp Pharmacol Physiol,33,612-616.
  24. Cheng, PW,Ng, LT,Lin, CC(2006).Xiao chai hu tang inhibits CVB1 virus infection of CCFS‑1 cells through the induction of Type I interferon expression.Int Immunopharmacol,6,1003-1012.
  25. Chentoufi, AA,Benmohamed, L(2012).Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.Clin Dev Immunol,2012,149135.
  26. Chiang, LC,Ng, LT,Cheng, PW,Chiang, W,Lin, CC(2005).Antiviral activities of extracts and selected pure constituents of Ocimum basilicum.Clin Exp Pharmacol Physiol,32,811-816.
  27. Chiang, LC,Ng, LT,Liu, LT,Shieh, DE,Lin, CC(2003).Cytotoxicity and anti‑hepatitis B virus activities of saikosaponins from Bupleurum species.Planta Med,69,705-709.
  28. Choi, HJ,Lim, CH,Song, JH,Baek, SH,Kwon, DH(2009).Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses.Phytomedicine,16,35-39.
  29. Choi, HJ,Song, JH,Park, KS,Baek, SH(2010).In vitro anti‑enterovirus 71 activity of gallic acid from Woodfordia fruticosa flowers.Lett Appl Microbiol,50,438-440.
  30. Christou, L(2011).The global burden of bacterial and viral zoonotic infections.Clin Microbiol Infect,17,326-330.
  31. Ciesek, S,von Hahn, T,Colpitts, CC,Schang, LM,Friesland, M,Steinmann, J(2011).The green tea polyphenol, epigallocatechin‑3‑gallate, inhibits hepatitis C virus entry.Hepatology,54,1947-1955.
  32. Clements, CJ,Cutts, FT(1995).The epidemiology of measles: Thirty years of vaccination.Curr Top Microbiol Immunol,191,13-33.
  33. Cos, P,Hermans, N,De Bruyne, T,Apers, S,Sindambiwe, JB,Vanden Berghe, D(2002).Further evaluation of Rwandan medicinal plant extracts for their antimicrobial and antiviral activities.J Ethnopharmacol,79,155-163.
  34. Cos, P,Maes, L,Vlietinck, A,Pieters, L(2008).Plant‑derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection‑an update (1998‑2007).Planta Med,74,1323-1337.
  35. Cui, X,Wang, Y,Kokudo, N,Fang, D,Tang, W(2010).Traditional Chinese medicine and related active compounds against hepatitis B virus infection.Biosci Trends,4,39-47.
  36. Danaher, RJ,Wang, C,Dai, J,Mumper, RJ,Miller, CS(2011).Antiviral effects of blackberry extract against herpes simplex virus type 1.Oral Surg Oral Med Oral Pathol Oral Radiol Endod,112,e31-e35.
  37. Dao, TT,Dang, TT,Nguyen, PH,Kim, E,Thuong, PT,Oh, WK(2012).Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.Bioorg Med Chem Lett,22,3688-3692.
  38. Dao, TT,Nguyen, PH,Lee, HS,Kim, E,Park, J,Lim, SI(2011).Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata.Bioorg Med Chem Lett,21,294-298.
  39. Eccles, R(2005).Understanding the symptoms of the common cold and influenza.Lancet Infect Dis,5,718-725.
  40. El‑Serag, HB(2012).Epidemiology of viral hepatitis and hepatocellular carcinoma.Gastroenterology,142,1264-1273.e1.
  41. Evans, A,Lee, R,Mammen‑Tobin, A,Piyadigamage, A,Shann, S,Waugh, M(2004).HIV revisited: The global impact of the HIV/AIDS epidemic.Skinmed,3,149-156.
  42. Falsey, AR,Walsh, EE(2000).Respiratory syncytial virus infection in adults.Clin Microbiol Rev,13,371-384.
  43. Fatahzadeh, M,Schwartz, RA(2007).Human herpes simplex labialis.Clin Exp Dermatol,32,625-630.
  44. Ferenci, P,Scherzer, TM,Kerschner, H,Rutter, K,Beinhardt, S,Hofer, H(2008).Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.Gastroenterology,135,1561-1567.
  45. Fiore, AE,Fry, A,Shay, D,Gubareva, L,Bresee, JS,Uyeki, TM(2011).Antiviral agents for the treatment and chemoprophylaxis of influenza ‑‑‑ recommendations of the Advisory Committee on Immunization Practices(ACIP).MMWR Recomm Rep,60,1-24.
  46. Franco, E,Bagnato, B,Marino, MG,Meleleo, C,Serino, L,Zaratti, L(2012).Hepatitis B: Epidemiology and prevention in developing countries.World J Hepatol,4,74-80.
  47. Geller, C,Varbanov, M,Duval, RE(2012).Human coronaviruses: Insights into environmental resistance and its influence on the development of new antiseptic strategies.Viruses,4,3044-3068.
  48. Geretti, AM,Armenia, D,Ceccherini‑Silberstein, F(2012).Emerging patterns and implications of HIV‑1 integrase inhibitor resistance.Curr Opin Infect Dis,25,677-686.
  49. Gescher, K,Kuhn, J,Hafezi, W,Louis, A,Derksen, A,Deters, A(2011).Inhibition of viral adsorption and penetration by an aqueous extract from Rhododendron ferrugineum L. as antiviral principle against herpes simplex virus type‑1.Fitoterapia,82,408-413.
  50. Gescher, K,Kuhn, J,Lorentzen, E,Hafezi, W,Derksen, A,Deters, A(2011).Proanthocyanidin‑enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration.J Ethnopharmacol,134,468-474.
  51. Ghosh, RK,Ghosh, SM,Chawla, S.(2011).Recent advances in antiretroviral drugs.Expert Opin Pharmacother,12,31-46.
  52. Glezen, WP,Taber, LH,Frank, AL,Kasel, JA(1986).Risk of primary infection and reinfection with respiratory syncytial virus.Am J Dis Child,140,543-546.
  53. Grais, RF,Strebel, P,Mala, P,Watson, J,Nandy, R,Gayer, M(2011).Measles vaccination in humanitarian emergencies: A review of recent practice.Confl Health,5,21.
  54. Grienke, U,Schmidtke, M,von Grafenstein, S,Kirchmair, J,Liedl, KR,Rollinger, JM(2012).Influenza neuraminidase: A druggable target for natural products.Nat Prod Rep,29,11-36.
  55. Haid, S,Novodomska, A,Gentzsch, J,Grethe, C,Geuenich, S,Bankwitz, D(2012).A plant‑derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.Gastroenterology,143,213-222.e5.
  56. Hall, CB(1994).Prospects for a respiratory syncytial virus vaccine.Science,265,1393-1394.
  57. Hall, CB,Long, CE,Schnabel, KC(2001).Respiratory syncytial virus infections in previously healthy working adults.Clin Infect Dis,33,792-796.
  58. Hall, CB,Walsh, EE,Long, CE,Schnabel, KC(1991).Immunity to and frequency of reinfection with respiratory syncytial virus.J Infect Dis,163,163-698.
  59. Hao, BJ,Wu, YH,Wang, JG,Hu, SQ,Keil, DJ,Hu, HJ(2012).Hepatoprotective and antiviral properties of isochlorogenic acid A from Laggera alata against hepatitis B virus infection.J Ethnopharmacol,144,190-194.
  60. Hayashi, T,Hayashi, K,Maeda, M,Kojima, I(1996).Calcium spirulan, an inhibitor of enveloped virus replication, from a blue‑green alga Spirulina platensis.J Nat Prod,59,83-87.
  61. He, W,Han, H,Wang, W,Gao, B(2011).Anti‑influenza virus effect of aqueous extracts from dandelion.Virol J,8,538.
  62. Henderson, FW,Collier, AM,Clyde, WA, Jr.,Denny, FW(1979).Respiratory‑syncytial‑virus infections, reinfections and immunity. A prospective, longitudinal study in young children.N Engl J Med,300,530-534.
  63. Ho, HY,Cheng, ML,Weng, SF,Leu, YL,Chiu, DT(2009).Antiviral effect of epigallocatechin gallate on enterovirus 71.J Agric Food Chem,57,6140-6147.
  64. Hober, D,Sane, F,Jaidane, H,Riedweg, K,Goffard, A,Desailloud, R(2012).Immunology in the clinic review series; focus on type 1 diabetes and viruses: Role of antibodies enhancing the infection with Coxsackievirus‑B in the pathogenesis of type 1 diabetes.Clin Exp Immunol,168,47-51.
  65. Hood, JL,Jallouk, AP,Campbell, N,Ratner, L,Wickline, SA(2013).Cytolytic nanoparticles attenuate HIV‑1 infectivity.Antivir Ther,18,95-103.
  66. Hsu, MJ,Hung, SL(2013).Antiherpetic potential of 6‑bromoindirubin‑3’‑ acetoxime (BIO‑acetoxime) in human oral epithelial cells.Arch Virol,158,1287-1296.
  67. Huang, SP,Shieh, GJ,Lee, L,Teng, HJ,Kao, ST,Lin, JG(1997).Inhibition effect of shengma‑gegen‑tang on measles virus in Vero cells and human peripheral blood mononuclear cells.Am J Chin Med,25,89-96.
  68. Huang, SW,Kiang, D,Smith, DJ,Wang, JR(2011).Evolution of re‑emergent virus and its impact on enterovirus 71 epidemics.Exp Biol Med,236,899-908.
  69. Huang, W,Zhang, X,Wang, Y,Ye, W,Ooi, VE,Chung, HY(2010).Antiviral biflavonoids from Radix Wikstroemiae (Liaogewanggen).Chin Med,5,23.
  70. Huerta‑Reyes, M,Basualdo Mdel, C,Abe, F,Jimenez‑Estrada, M,Soler, C,Reyes‑Chilpa, R(2004).HIV‑1 inhibitory compounds from Calophyllum brasiliense leaves.Biol Pharm Bull,27,1471-1475.
  71. Jeong, HJ,Kim, YM,Kim, JH,Kim, JY,Park, JY,Park, SJ(2012).Homoisoflavonoids from Caesalpinia sappan displaying viral neuraminidases inhibition.Biol Pharm Bull,35,786-790.
  72. Jiang, ZY,Liu, WF,Zhang, XM,Luo, J,Ma, YB,Chen, JJ(2013).Anti‑HBV active constituents from Piper longum.Bioorg Med Chem Lett,23,2123-2127.
  73. Khan, MT,Ather, A,Thompson, KD,Gambari, R(2005).Extracts and molecules from medicinal plants against herpes simplex viruses.Antiviral Res,67,107-119.
  74. Kim, K,Kim, KH,Kim, HY,Cho, HK,Sakamoto, N,Cheong, J(2010).Curcumin inhibits hepatitis C virus replication via suppressing the Akt‑SREBP‑1 pathway.FEBS Lett,584,707-712.
  75. Kim, SK,Karadeniz, F(2011).Anti‑HIV activity of extracts and compounds from marine algae.Adv Food Nutr Res,64,255-265.
  76. Koishi, AC,Zanello, PR,Bianco, EM,Bordignon, J,Nunes Duarte dos Santos, C(2012).Screening of Dengue virus antiviral activity of marine seaweeds by an in situ enzyme‑linked immunosorbent assay.PLoS One,7,e51089.
  77. Krawitz, C,Mraheil, MA,Stein, M,Imirzalioglu, C,Domann, E,Pleschka, S(2011).Inhibitory activity of a standardized elderberry liquid extract against clinically‑relevant human respiratory bacterial pathogens and influenza A and B viruses.BMC Complement Altern Med,11,16.
  78. Kudo, E,Taura, M,Matsuda, K,Shimamoto, M,Kariya, R,Goto, H(2013).Inhibition of HIV‑1 replication by a tricyclic coumarin GUT‑70 in acutely and chronically infected cells.Bioorg Med Chem Lett,23,606-609.
  79. Kurokawa, M,Ochiai, H,Nagasaka, K,Neki, M,Xu, H,Kadota, S(1993).Antiviral traditional medicines against herpes simplex virus (HSV‑1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV‑1 infection in mice.Antiviral Res,22,175-188.
  80. Kwon, H,Lok, AS(2011).Hepatitis B therapy.Nat Rev Gastroenterol Hepatol,8,275-284.
  81. Lau, KM,Lee, KM,Koon, CM,Cheung, CS,Lau, CP,Ho, HM(2008).Immunomodulatory and anti‑SARS activities of Houttuynia cordata.J Ethnopharmacol,118,79-85.
  82. Li, SY,Chen, C,Zhang, HQ,Guo, HY,Wang, H,Wang, L(2005).Identification of natural compounds with antiviral activities against SARS‑associated coronavirus.Antivir Res,67,18-23.
  83. Liang, TJ(2009).Hepatitis B: The virus and disease.Hepatology,49(5 Suppl),S13-S21.
  84. Lin, CW,Tsai, FJ,Tsai, CH,Lai, CC,Wan, L,Ho, TY(2005).Anti‑SARS coronavirus 3C‑like protease effects of Isatis indigotica root and plant‑derived phenolic compounds.Antivir Res,68,36-42.
  85. Lin, LT,Chen, TY,Chung, CY,Noyce, RS,Grindley, TB,McCormick, C(2011).Hydrolyzable tannins(chebulagic acid and punicalagin) target viral glycoprotein‑glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell‑to‑cell spread.J Virol,85,4386-4398.
  86. Lin, LT,Chen, TY,Lin, SC,Chung, CY,Lin, TC,Wang, GH(2013).Broad‑spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.BMC Microbiol,13,187.
  87. Lin, YM,Flavin, MT,Schure, R,Chen, FC,Sidwell, R,Barnard, DL(1999).Antiviral activities of biflavonoids.Planta Med,65,120-125.
  88. Locarnini, SA,Yuen, L(2010).Molecular genesis of drug‑resistant and vaccine‑escape HBV mutants.Antivir Ther,15,451-461.
  89. Low, JS,Wu, KX,Chen, KC,Ng, MM,Chu, JJ(2011).Narasin, a novel antiviral compound that blocks dengue virus protein expression.Antivir Ther,16,1203-1218.
  90. Lubbe, A,Seibert, I,Klimkait, T,van der Kooy, F(2012).Ethnopharmacology in overdrive: The remarkable anti‑HIV activity of Artemisia annua.J Ethnopharmacol,141,854-859.
  91. Ma, LY,Ma, SC,Wei, F,Lin, RC,But, PP,Lee, SH(2003).Uncinoside A and B, two new antiviral chromone glycosides from Selaginella uncinata.Chem Pharm Bull,51,1264-1267.
  92. Ma, SG,Gao, RM,Li, YH,Jiang, JD,Gong, NB,Li, L(2013).Antiviral Spirooliganones A and B with Unprecedented Skeletons from the Roots of Illicium oligandrum.Org Lett,15,4450-4453.
  93. Mak, PW,Jayawardena, S,Poon, LL(2012).The evolving threat of influenza viruses of animal origin and the challenges in developing appropriate diagnostics.Clin Chem,58,1527-1533.
  94. Margolis, AM,Heverling, H,Pham, PA,Stolbach, A.A review of the toxicity of HIV medications.J Med Toxicol
  95. Marino, Z,Crespo, G,D’Amato, M,Brambilla, N,Giacovelli, G,Rovati, L(2013).Intravenous silibinin monotherapy shows significant antiviral activity in HCV‑infected patients in the peri‑transplantation period.J Hepatol,58,415-420.
  96. McWhorter, JH(1996).Spicebush. A Cherokee remedy for the measles.N C Med J,57,306.
  97. Meuleman, P,Albecka, A,Belouzard, S,Vercauteren, K,Verhoye, L,Wychowski, C(2011).Griffithsin has antiviral activity against hepatitis C virus.Antimicrob Agents Chemother,55,5159-5167.
  98. Morfin, F,Thouvenot, D(2003).Herpes simplex virus resistance to antiviral drugs.J Clin Virol,26,29-37.
  99. Morgan, RL,Baack, B,Smith, BD,Yartel, A,Pitasi, M,Falck‑Ytter, Y(2013).Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: Ameta‑analysis of observational studies.Ann Intern Med,158,329-337.
  100. Moss, JA(2013).HIV/AIDS Review.Radiol Technol,84,247-267.
  101. Mossong, J,Muller, CP(2003).Modelling measles re‑emergence as a result of waning of immunity in vaccinated populations.Vaccine,21,4597-4603.
  102. Murray, CJ,Lopez, AD(1997).Mortality by cause for eight regions of the world: Global Burden of Disease Study.Lancet,349,1269-1276.
  103. Neumann, UP,Biermer, M,Eurich, D,Neuhaus, P,Berg, T(2010).Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono‑therapy.J Hepatol,52,951-952.
  104. Ni, YH,Chen, DS(2010).Hepatitis B vaccination in children: The Taiwan experience.Pathologiebiologie,58,296-300.
  105. Nwodo, UU,Ngene, AA,Iroegbu, CU,Onyedikachi, OA,Chigor, VN,Okoh, AI(2011).In vivo evaluation of the antiviral activity of Cajanus cajan on measles virus.Arch Virol,156,1551-1557.
  106. Olila, D,Olwa, O,Opuda‑Asibo, J(2002).Screening extracts of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus(Swartz and Edmonston strains) in vitro.Afr Health Sci,2,2-10.
  107. Parker, ME,Chabot, S,Ward, BJ,Johns, T(2007).Traditional dietary additives of the Maasai are antiviral against the measles virus.J Ethnopharmacol,114,146-152.
  108. Petrera, E,Coto, CE(2009).Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection.Phytother Res,23,1771-1777.
  109. Petricevich, VL,Mendonca, RZ(2003).Inhibitory potential of Crotalus durissus terrificus venom on measles virus growth.Toxicon,42,143-153.
  110. Piot, P,Quinn, TC(2013).Response to the AIDS pandemic: A global health model.N Engl J Med,368,2210-2218.
  111. Pleschka, S.(2013).Overview of influenza viruses.Curr Top Microbiol Immunol,370,1-20.
  112. Polyak, SJ,Morishima, C,Lohmann, V,Pal, S,Lee, DY,Liu, Y(2010).Identification of hepatoprotective flavonolignans from silymarin.Proc Natl Acad Sci U S A,107,5995-5999.
  113. Polyak, SJ,Morishima, C,Shuhart, MC,Wang, CC,Liu, Y,Lee, DY(2007).Inhibition of T‑cell inflammatory cytokines, hepatocyte NF‑kappaB signaling, and HCV infection by standardized Silymarin.Gastroenterology,132,1925-1936.
  114. Qiu, LP,Chen, KP(2013).Anti‑HBV agents derived from botanical origin.Fitoterapia,84,140-157.
  115. Rechtman, MM,Har‑Noy, O,Bar‑Yishay, I,Fishman, S,Adamovich, Y,Shaul, Y(2010).Curcumin inhibits hepatitis B virus via down‑regulation of the metabolic coactivator PGC‑1alpha.FEBS Lett,584,2485-2490.
  116. Rello, J,Pop‑Vicas, A(2009).Clinical review: Primary influenza viral pneumonia.Crit Care,13,235.
  117. Ruuskanen, O,Ogra, PL(1993).Respiratory syncytial virus.Curr Probl Pediatr,23,50-79.
  118. Ryu, YB,Jeong, HJ,Kim, JH,Kim, YM,Park, JY,Kim, D(2010).Biflavonoids from Torreya nucifera displaying SARS‑CoV 3CL(pro) inhibition.Bioorg Med Chem,18,7940-7947.
  119. Sabella, C(2010).Measles: Not just a childhood rash.Cleve Clin J Med,77,207-213.
  120. Sagar, S,Kaur, M,Minneman, KP(2010).Antiviral lead compounds from marine sponges.Mar Drugs,8,2619-2638.
  121. Sam, SS,Omar, SF,Teoh, BT,Abd‑Jamil, J,AbuBakar, S(2013).Review of Dengue hemorrhagic fever fatal cases seen among adults: A retrospective study.PLoS Negl Trop Dis,7,e2194.
  122. Samson, M,Pizzorno, A,Abed, Y,Boivin, G(2013).Influenza virus resistance to neuraminidase inhibitors.Antiviral Res,98,174-185.
  123. Shaw, GM,Hunter, E(2012).HIV transmission.Cold Spring Harb Perspect Med,2(11)
  124. Sheu, TG,Deyde, VM,Okomo‑Adhiambo, M,Garten, RJ,Xu, X,Bright, RA(2008).Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.Antimicrob Agents Chemother,52,3284-3292.
  125. Sierra, S,Kupfer, B,Kaiser, R(2005).Basics of the virology of HIV‑1 and its replication.J Clin Virol,34,233-244.
  126. Sigurs, N,Gustafsson, PM,Bjarnason, R,Lundberg, F,Schmidt, S,Sigurbergsson, F(2005).Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.Am J Respir Crit Care Med,171,137-141.
  127. Singh, IP,Bodiwala, HS(2010).Recent advances in anti‑HIV natural products.Nat Prod Rep,27,1781-1800.
  128. Superti, F,Ammendolia, MG,Marchetti, M(2008).New advances in anti‑HSV chemotherapy.Curr Med Chem,15,900-911.
  129. Takebe, Y,Saucedo, CJ,Lund, G,Uenishi, R,Hase, S,Tsuchiura, T(2013).Antiviral lectins from red and blue‑green algae show potent in vitro and in vivo activity against hepatitis C virus.PLoS One,8,e64449.
  130. Tamura, S,Yang, GM,Yasueda, N,Matsuura, Y,Komoda, Y,Murakami, N.,Tellimagrandin, I(2010).HCV invasion inhibitor from Rosae Rugosae Flos.Bioorg Med Chem Lett,20,1598-1600.
  131. Tapparel, C,Siegrist, F,Petty, TJ,Kaiser, L(2013).Picornavirus and enterovirus diversity with associated human diseases.Infect Genet Evol,14,282-293.
  132. Theisen, LL,Muller, CP(2012).EPs(R) 7630 (Umckaloabo (R)), an extract from Pelargonium sidoides roots, exerts anti‑influenza virus activity in vitro and in vivo.Antiviral Res,94,147-156.
  133. van der Hoek, L(2007).Human coronaviruses: What do they cause?.Antivir Ther,12,651-658.
  134. van der Vries, E,Collins, PJ,Vachieri, SG,Xiong, X,Liu, J,Walker, PA(2012).H1N1 2009 pandemic influenza virus: Resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis.PLoS Pathog,8,e1002914.
  135. Vo, TS,Kim, SK(2010).Potential anti‑HIV agents from marine resources: An overview.Mar Drugs,8,2871-2892.
  136. Vo, TS,Ngo, DH,Ta, QV,Kim, SK(2011).Marine organisms as a therapeutic source against herpes simplex virus infection.Eur J Pharm Sci,44,11-20.
  137. Wang, KC,Chang, JS,Chiang, LC,Lin, CC(2012).Cimicifuga foetida L. inhibited human respiratory syncytial virus in HEp‑2 and A549 cell lines.Am J Chin Med,40,151-162.
  138. Wang, KC,Chang, JS,Chiang, LC,Lin, CC(2011).Sheng‑Ma‑Ge‑Gen‑Tang (Shoma‑kakkon‑to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.J Ethnopharmacol,135,538-544.
  139. Wang, KC,Chang, JS,Lin, LT,Chiang, LC,Lin, CC(2012).Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus.Am J Chin Med,40,1033-1045.
  140. Wang, LJ,Geng, CA,Ma, YB,Huang, XY,Luo, J,Chen, H(2012).Synthesis, biological evaluation and structure‑activity relationships of glycyrrhetinic acid derivatives as novel anti‑hepatitis B virus agents.Bioorg Med Chem Lett,22,3473-3479.
  141. Wang, SM,Ho, TS,Lin, HC,Lei, HY,Wang, JR,Liu, CC(2012).Reemerging of enterovirus 71 in Taiwan: The age impact on disease severity.Eur J Clin Microbiol Infect Dis,31,1219-1224.
  142. Wang, Y,Chen, M,Zhang, J,Zhang, XL,Huang, XJ,Wu, X(2012).Flavone C‑glycosides from the leaves of Lophatherum gracile and their in vitro antiviral activity.Planta Med,78,46-51.
  143. Welsch, C,JesudianA,Zeuzem, S,Jacobson, I(2012).New direct‑acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.Gut,61(Suppl 1),i36-i46.
  144. Wyles, DL(2013).Antiviral resistance and the future landscape of hepatitis C virus infection therapy.J Infect Dis,207(Suppl 1),S33-S39.
  145. Xie, Y,Huang, B,Yu, K,Shi, F,Liu, T,Xu, W(2013).Caffeic acid derivatives: A new type of influenza neuraminidase inhibitors.Bioorg Med Chem Lett,23,3556-3560.
  146. Yamada, S,Suzuki, Y,Suzuki, T,Le, MQ,Nidom, CA,Sakai‑Tagawa, Y(2006).Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human‑type receptors.Nature,444,378-382.
  147. Yang, CM,Cheng, HY,Lin, TC,Chiang, LC,Lin, CC(2007).Hippomanin A from acetone extract of Phyllanthus urinaria inhibited HSV‑2 but not HSV‑1 infection in vitro.Phytother Res,21,1182-1186.
  148. Yang, CM,Cheng, HY,Lin, TC,Chiang, LC,Lin, CC(2007).The in vitro activity of geraniin and 1,3,4,6‑tetra‑O‑galloyl‑beta‑D‑glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection.J Ethnopharmacol,110,555-558.
  149. Yu, MS,Lee, J,Lee, JM,Kim, Y,Chin, YW,Jee, JG(2012).Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.Bioorg Med Chem Lett,22,4049-4054.
  150. Zandi, K,Teoh, BT,Sam, SS,Wong, PF,Mustafa, MR,Abubakar, S(2011).Antiviral activity of four types of bioflavonoid against dengue virus type‑2.Virol J,8,560.
  151. Zandi, K,Teoh, BT,Sam, SS,Wong, PF,Mustafa, MR,Abubakar, S(2012).Novel antiviral activity of baicalein against dengue virus.BMC Complement Altern Med,12,214.
  152. Zandotti, C,Jeantet, D,Lambert, F,Waku‑Kouomou, D,Wild, F,Freymuth, F(2004).Re‑emergence of measles among young adults in Marseilles, France.Eur J Epidemiol,19,891-893.
  153. Zang, N,Xie, X,Deng, Y,Wu, S,Wang, L,Peng, C(2011).Resveratrol‑mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus‑infected immunocompromised mice.J Virol,8,13061-13068.
  154. Zeng, FL,Xiang, YF,Liang, ZR,Wang, X,Huang, DE,Zhu, SN(2013).Anti‑hepatitis B virus effects of dehydrocheilanthifoline from Corydalis saxicola.Am J Chin Med,41,119-130.
  155. Zhan, P,Jiang, X,Liu, X(2010).Naturally occurring and synthetic bioactive molecules as novel non‑nucleoside HBV inhibitors.Mini Rev Med Chem,10,162-171.
  156. Zhang, L,Wang, G,Hou, W,Li, P,Dulin, A,Bonkovsky, HL(2010).Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review.Hepatology,51,690-698.
  157. Zhou, X,Liu, J,Yang, B,Lin, X,Yang, XW,Liu, Y(2013).Marine natural products with anti‑HIV activities in the last decade.Curr Med Chem,20,953-973.
被引用次数
  1. Tewin Tencomnao,Siriporn Chuchawankul,Panthakarn Rangsinth,Chanin Sillapachaiyaporn,Atsadang Theerasri,Anchalee Prasansuklab(2021).Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.Journal of Traditional and Complementary Medicine,11(2),144-157.
print cancel